Sjogren Syndrome Antigen B (SSB) Peptide
SSB
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all SSB products
- SSB (Sjogren Syndrome Antigen B (SSB))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- ISEDKTKIRR SPSKPLPEVT DEYKNDVKNR SVYIKGFPTD ATLDDIKEWL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SSB antibody,
Alternative Names: SSB control peptide, SSB antibody Blocking Peptide, Anti-SSB Blocking Peptide, Sjogren Syndrome Antigen B Blocking Peptide, Autoantigen La Blocking Peptide, LARP3 Blocking Peptide, La Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- SSB (Sjogren Syndrome Antigen B (SSB))
- Background
- SSB is involved in diverse aspects of RNA metabolism, including binding and protecting 3-prime UUU(OH) elements of newly RNA polymerase III-transcribed RNA, processing 5-prime and 3-prime ends of pre-tRNA precursors, acting as an RNA chaperone, and binding viral RNAs associated with hepatitis C virus. SSB protein was originally defined by its reactivity with autoantibodies from patients with Sjogren syndrome and systemic lupus erythematosus.
- Molecular Weight
- 45 kDa
-
You are here:
